View Single Post
Old 04-21-2015, 01:06 PM   #21
vqtilley
Member
 
Join Date: Mar 2015
Posts: 13
Re: TDM1 for HER2+ brain mets reocurrence?

Thanks so much, extraordinary story! Yes, I'm sure I'll have more questions and curiosity and may email you separately soon. I'm at work now so will have to ponder all this. But for the moment I'm just amazed and impressed at Nina's progress. Inspirational and very useful for my next consultations on the 13th, particularly if we see lepto progressing on the MRIs. Is any of this history, approach and success being written up by her doctors in Houston? It works better to thump something down on my doctor's tables than to say "I read in a forum on line" even if it's this forum.
__________________
Feb 2012: diagnosed with 1 cm lesion rt breast, DCIS left breast, Stage IV ER+/HER2+
Apr 2012: bilateral partial excisions; confirmed met to left proximal femur, long gamma nail inserted to stabilize femur:
May 2012: radiation to femur: chemo with Trastuzumab + taxane.
July 2012 thru Mar 2015: started maintenance regime Herceptin+Arimidex+Denosumab, NED
May 2014: recurrence in right acetabulum: 15 fractions radiation
Jan 2015: lesion in left cerebellum: resection & gamma knife treatment
Mar 2015: major general progression; small mets confirmed in rt axilla, rt breast, T7 vertebra, possible met as isolated spiculated pulmonary nodule left lung[LIST][*]27 Mar 2015: start Kadcyla, discontinue aromotase inhibitors; within two weeks axilla/rt breast lesions are shrinking noticeably[*]18 April: resume letrozole [*]May: all lesions disappeared or dormant[*]June - discontinue Kadcyla due to low platelets[*]Aug & Nov 2015 MRI brain/spinal scans all negative for CNS disease: no recurrence to date
Fall 2015 - stereotactic radiation to lingering T3 lesion to relieve pain; 90% effective within weeks
July 2019 - discontinued Letrozole due to side effects
April 2020 - short course steretactic radiation to 2 cm lesion in upper left lung; subsequent scan finds it reduced
Mar 2021 - 6.5 cm mass found in left lung; FISH finds it is PR-, ER- and strongly HER2+.
16 April 2021 - Resume Kadcyla.
vqtilley is offline   Reply With Quote